🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tezepelumab is a treatment that is approved by NICE (National Institute for...
Status
Completed
Location
Guys & St Thomas NHS Foundation Trust
Start Date
2024-12-11
Trial ID
NCT06666504
Treatments Being Tested
This retrospective data repository will serve as a means to aggregate and a...
Status
Recruiting
Location
Methodist Dallas Medical Center- Clinical Research Institute
Start Date
2024-02-16
Trial ID
NCT07490158
Treatments Being Tested
Mutations in the CAPN3 gene cause muscular dystrophies with dysfunction in ...
Status
Unknown
Location
San Camillo Irccs
Start Date
2023-09-01
Trial ID
NCT05956132
Treatments Being Tested
Bullous pemphigoid affects mainly elderly patients. It is often associated ...
Status
Completed
Location
Damien JOLLY
Start Date
2013-10-01
Trial ID
NCT03320798
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of ustekinumab i...
Status
Completed
Location
ImproveCareNow, Inc.
Start Date
2022-03-21
Trial ID
NCT05242458
Treatments Being Tested
The purpose of this study is to learn how to use blood tests to better pred...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-02-01
Trial ID
NCT04791215
Treatments Being Tested
This study used a retrospective dataset collected by Optina under different...
Status
Completed
Location
Optina Diagnostics Inc
Start Date
2024-12-24
Trial ID
NCT06860568
Treatments Being Tested
An article to present how cancer patients were taken in charge at Lyon Univ...
Status
Completed
Location
Lyon University Hospital Cancer Institute
Start Date
2020-12-02
Trial ID
NCT04910633
Treatments Being Tested
Sickle cell patients have a high prevalence of alloimmunization. This high ...
Status
Withdrawn
Location
CHU Brugmann
Start Date
2018-02-01
Trial ID
NCT03401125
Treatments Being Tested
The specific construction goals for this period include enrolling 100,000 i...
Status
Recruiting
Location
Physical Examination Center, Peking University Third Hospital
Start Date
2025-02-21
Trial ID
NCT07761676
Treatments Being Tested